Related Experiment Video

Updated: Jun 28, 2026

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood
07:26

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood

Published on: September 14, 2017

Endothelial progenitor cells in cell-based therapy for cardiovascular disease

N Rodriguez-Losada1, J M Garcia-Pinilla, M F Jimenez-Navarro

  • 1Virgen de la Victoria University Hospital, Campus Teatinos s/n Research Laboratory, Heart Unit, Malaga, Spain.

Cellular and Molecular Biology (Noisy-Le-Grand, France)
|October 29, 2008
PubMed

Insights

Bone marrow-derived endothelial progenitor cells (EPCs) show potential for cardiac repair in Coronary Artery Diseases (CAD). Research focuses on characterizing EPCs and their homing capabilities for effective cell therapy in treating heart tissue damage.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Coronary Artery Diseases (CAD) are a leading cause of mortality globally.
  • Cell therapy offers a promising approach for regenerating damaged myocardium.
  • Bone marrow-derived stem/progenitor cells are crucial for human cardiac repair.

Purpose of the Study:

  • To review the characterization of bone marrow-derived endothelial progenitor cells (EPCs).
  • To examine the homing mechanisms and differentiation potential of EPCs in ischemic tissues.
  • To summarize clinical studies utilizing bone marrow-derived progenitor cells for CAD treatment.

Main Methods:

  • Literature review of studies on EPC phenotype characterization (CD133, CD34, KDR).
  • Analysis of EPC mobilization, recruitment, and homing to ischemic areas.
  • Compilation of data from clinical trials involving bone marrow-derived cells in CAD.

Main Results:

  • EPCs home to ischemic sites and promote neovascularization.
  • EPCs exhibit complex phenotypes, expressing both hematopoietic and endothelial markers.
  • Clinical studies demonstrate the potential of bone marrow-derived progenitor cells in cardiac tissue repair for CAD patients.

Conclusions:

  • Bone marrow-derived EPCs are a key focus for cardiac regenerative therapy.
  • Further characterization of EPC phenotypes and homing is essential for optimizing cell-based treatments.
  • Clinical applications show promise for improving cardiac function in CAD.

More Related Videos

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood13:46

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood

Published on: April 13, 2012

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.